{"id":"W2752446656","doi":"10.3310/hta21490","title":"Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness","year":2017,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University","funders":"Health Technology Assessment Programme; National Institutes of Health; H. Lundbeck A/S; University of Sheffield; Otsuka Pharmaceutical; Cilag; University of Manchester; Sunovion; University of Southampton; National Institute for Health and Care Research; Amicus Therapeutics; Eli Lilly and Company","keywords":"Amisulpride; Clozapine; Medicine; Placebo; Antipsychotic; Schizophrenia (object-oriented programming); Randomized controlled trial; Atypical antipsychotic; Positive and Negative Syndrome Scale; Odds ratio; Psychiatry; Internal medicine; Psychosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007853269,0.000371961,0.002388106,0.0008684999,0.0004053795,0.00004583945,0.0002836983,0.0004903267,0.00001755415],"category_scores_gemma":[0.001820184,0.0002978766,0.0002610836,0.0002751178,0.0006260633,0.0001505662,0.0002157263,0.0009903447,0.000007428235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006186559,"about_ca_system_score_gemma":0.002703835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003576791,"about_ca_topic_score_gemma":0.0004225157,"domain_scores_codex":[0.9948348,0.001726752,0.001459693,0.0008141226,0.0005242766,0.0006403421],"domain_scores_gemma":[0.9947484,0.002539207,0.001095293,0.001025238,0.0002650984,0.0003268021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8623928,0.001545687,0.03624915,0.0003761994,0.000510559,0.0001415186,0.00001692732,0.000005700959,0.0003137953,0.00389646,0.000009546136,0.0945417],"study_design_scores_gemma":[0.6813462,0.004918251,0.3104971,0.0004921328,0.0001180123,0.00003518635,0.00007670924,0.0002292807,0.00130891,0.0008175558,0.00002860061,0.0001320569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678965,0.000673189,0.000601175,0.005178402,0.0004365261,0.02497907,0.00001746031,0.00009219301,0.0001254421],"genre_scores_gemma":[0.9880813,0.001340489,0.002639886,0.00005964776,0.0000905538,0.007698724,0.00003625369,0.00003398636,0.00001914169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2742479,"threshold_uncertainty_score":0.9999473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.101375323326093,"score_gpt":0.5039599870569764,"score_spread":0.4025846637308834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}